Company / Free Cash Flow
Co-Diagnostics, Inc. Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$29.8M
FY2025
5-year range
-$29.9M / $40.4M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$30M.
Based on SEC 10-K filings.
-$30M in FY2025.
Declined from -$23M to -$30M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 0.2% year-over-year.
- Peak free cash flow was recorded in FY2022.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$29.8M | +0.2% |
| FY2024 | -$29.9M | -27.5% |
| FY2023 | -$23.4M | -158.0% |
| FY2022 | $40.4M | +47.5% |
| FY2021 | $27.4M | +585.8% |
| FY2020 | -$5.6M | -36.8% |
| FY2019 | -$4.1M | -23.4% |
| FY2018 | -$3.3M | -152.2% |
| FY2017 | -$1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026